Diclofenac Sodium Solution
Product Images NDC 80425-0240

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 80425-0240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

FDA Label Image

Label1 (Diclofenac Sodium Solution 80425 0240 01)

Label1 (Diclofenac Sodium Solution 80425 0240 01)
This is a description of a medication called "DICLOFENAC SODIUM 1.5% SOLUTION". The bottle contains 150 ML of the solution and has a lot number of "150DIC" with an expiration date of 1/31/2024. The source NDC number is 70512-0038-05 and the lot number is 80425-0240-01. The serial number is "000000133083". Any other information is not available.*
FDA Label Image

Fig A (Fig 1)

FDA Label Image

Figure B And C (Fig B)

FDA Label Image

Table 2 (Table 2)

FDA Label Image

Table 1 (Table 1)

Table 1 (Table 1)
Treatment Group: Diclofenac Sodium Topical Solution, 15% w/w. The common adverse reactions reported with the topical application include dry skin, contact dermatitis, dyspepsia, abdominal pain, pruritus, diarrhea, nausea, pharyngitis, constipation, edema, rash, ecchymosis, vesicles on contact dermatitis, paresthesia, accidental injury, and halitosis. Dry skin and contact dermatitis (vesicles) are observed commonly during application, while paresthesia is occasionally reported with no application. Reactions varying from those specified might also occur.*
FDA Label Image

Tabve 3 (Table 3)

Tabve 3 (Table 3)
This appears to be a report or study that measures the efficacy of diclofenac sodium as a pain reliever versus placebo and vehicle (with and without DMSO) over a period of 12 weeks. The study seems to track changes in WOMAC pain score and WOMAC physical function.*
FDA Label Image

Table 4 (Table 4)

Table 4 (Table 4)
The text appears to be a table or chart with headings such as "Efficacy Variable" and measurements such as "WOMAC pain score" and "WOMAC physical function." It also includes numbers in the format of "Likert 31.069." Without further context or information, it is difficult to determine the exact purpose or meaning of this text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.